Last reviewed · How we verify
A Double-Blind, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of an Over-the-Counter Cream in the Management of Mild to Moderate Atopic Dermatitis in Children
This three week study will be conducted to determine the safety and efficacy of an over-the-counter (OTC) cream in children with mild to moderate atopic dermatitis.
Details
| Lead sponsor | Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 90 |
| Start date | 2011-03 |
| Completion | 2011-06 |
Conditions
- Atopic Dermatitis
Interventions
- Colloidal Oatmeal
- Topical Cream
Primary outcomes
- Eczema Area and Severity Index (EASI) — 3 weeks
A regional body surface area tabulation based on severity ranging from 0 (none) to 3 (severe), and severity of signs of disease, then multiplied by body area with final calculation ranging from 0-72
Countries
United States